abstract |
The present invention relates to a recombinant adeno-associated virus (AAV) for the expression in a cell of two functional monospecific antibodies having different types of specificity. Also described is a recombinant adeno-associated virus (AAV) for the expression of two functional monospecific antibodies and a bispecific antibody in a cell. The present invention also relates to a pharmaceutical composition for expressing two different functional monospecific antibodies having different types of specificity in a cell, to a method for delivering two functional monospecific antibodies having different types of specificity to a subject, as well as to a composition for delivering two functional monospecific antibodies having different types of specificity, subject. |